Background: Frailty recognized as a common clinical syndrome associated wih a high rate of morbidity and mortality. Aim of the Study: This study aimed at assessing the value of determination of some biomarkers in identification and recruitment of frail elderly. The association between these biomarkers and stages of frailty were also assessed Subjects and Methods : A total number of 100 elderly subjects (above 65 years old) were included in the work divided into three groups : Group 1 (non-frail) included 34 subjects (19 males and 15 females), their ages ranged from 66.3 to 72.9 with mean 67.6 + 3.3 year; Group 2 (pre-frail) included 26 subjects (1 males and 15 females), their ages ranged from 65.5 to 73.1 with mean age of 69.3 + 3.8 year and Group 3 (frail) included 40 subjects (25 males and 15 females), their ages ranged from 67.9+ to 78.3 with mean age of 73.1+5.2 year.All subjects of this study were subjected to : thorough clinical examination, Anthropometric measures (including mid upper arm circumference, mid calf circumference, body mass index), Timed get-up-and-go test, hand grip strengh test and laboratory investigations (including complete blood picture, serum albumin, serum alanine transferase, INR. Prothrombin time and partial thromboplastin time, Cholesterol and C-reactive protein.
INTRODUCTION
ver the past decade, clinicians and investigators have begun to recognize frailty as a common clinical syndrome associated with a high rate of morbidity and mortality, and therefore deserving rigorous investigations [1] . It has been postulated that there is a continuum of the severity of frailty ranging from non-frailty, prefrailty and frailty [2] . There is no single best definition of frailty [3] . The vernacular term frailty has been used to describe those who are feeble, weak, the most debilitated and the oldest old. Synonyms of frailty include defect, deficiency, error, failing, fallibility, imperfection, infirmity and susceptibility. Older adults or aged individuals who are lacking in general strength and are unusually susceptible to disease or to other infirmity [4] . Furthermore, no single altered system or etiology defines frailty [5,6]. Bold et al. [7] reported that clinical markers or indicators are insufficient to differentiate the frailty process from normal aging, and they gave rise to the necessity to detect frailty at a pre-clinical stage with the help of biomarkers.
Evaluation of alterations in human biomarkers and their relationships to differing models of frailty may assist in the determination of the initiation of the processes that eventually led to frailty [8] .
SUBJECTS AND METHODS This work had been carried out in Internal Medicine Departments, Faculty of Medicine, Zagazig University during the year 2011.
SUBJECTS :
A total number of 100 elderly subjects (above 65 years old) were included in the work recruited from those attending Zagazig University Hospitals for management of cataract and from day care center for geriatrics in Zagazig Governorate during the year 2011.
Ethical clearance :
Informed concent from the patients if possible or from their relatives to participate in the study. Inclusion criteria: we only considered subjects whose ages were above 65 years old and free of diseases as possible, for inclusion.
Matching of dietary habits and socioeconomic status were also criteria for inclusion. Exclusion criteria: subjects who had any known disabilities and/or comorbidities were excluded. Also subjects with a history of the following diseases were 
<270 kilocalories/wk
Exhaustion fatigue A score of 2 or 3 on either question of the CES-D How often in the last week did you feel this way? -I felt that everything I did was an effort -I could not get going 0= 1 day, 1= 1-2 days, 2= 2,3,4 days, 3= more than 4 days
METHODS :
All subjects of this study were subjected to thorough history taking, complete general examination (special attention to blood pressure and pulse Hand-grip strength test (done by hand-grip dyamometer); the purpose of this test is to measure the maximum isometric strength of the hand and forearm muscles. Hand-grip strength is important for any sport in which the hands are used for catching, throwing or lifting. Also, as a general rule people with strong hands tend to be strong elswhere, so this test is often used as a general test of strength [13, 14] and laboratory investigations that include : complete blood picture, serum albumin, serum alanine transferase, INR, Prothrombin time (PT), Partial Thromboplastin Time (PTT), Total cholesterol and Creactive protein (CRP) [10, 11] . RESULTS This work was carried out on 100 patients who were divided into three groups : Group 1 included 34 of non-frail subjects, it included 19 males and 15 females, their ages ranged from 66.3 to 72.9 with mean 67.6 + 3.3 year; Group 2 : Included 26 of prefrail subjects, it included 11 males and 15 females, their ages ranged from 65.5 to 73.1 with mean age of 69.3+3.8 year and Group 3 : Included 40 subjects study of some biomarkers in frail elderly with criteria of frailty, it included 25 males and 15 females, their ages ranged from 67.9 to 78.3 with mean age of 73.1 + 5.2 year. Table ( 1) showed significant difference between the studied groups regarding both age ( Fig. 1) and BMI ( Fig. 2) , while there was no significant difference between them as regards sex. Table ( 2) showed highly significant difference between the studied groups regarding TGUGT (Fig.  3) . Table ( 3) showed highly significant difference between the studied groups regarding MAC, while there was significant difference between them regarding CC (Fig. 4) . Table (4) showed highly significant difference between the studied groups as regards serum cholesterol (Fig. 6) , ALT (Fig. 8) , WBCs (Fig. 11) and CRP (Fig. 12 ) levels while there was significant difference between the studied groups as regards HB level (Fig. 5) , but regarding serum albumin, PT and INR levels there was no significant difference between them (Fig. 7, 9 and 10). As regard age of subjects, our study revealed significant elevation in age of frail subjects (731 + 5.2 year), compared to both pre-frail (69 + 3.8 year) and non-frail with non significant increase in prefrail compared to non-frail (67.6+3.3 year). These results give support to the study of Woods et al. [15] that reported significant association between age and frailty. Our study showed no significant association between gender and frailty. However, some investigators reported significant association between female gender and frailty [16] , and this may be explained by the included females in their studies suffered from many other comorbidities. In our study, we assessed several potential biomarkers of frailty. As regard hemoglobin concentration, we found significant decrease in Hb% (10.4+2.6 g/dl) in frail group compared to both pre-frail (13.3 + 1.9 g/dl) and non-frail (12.8 + 1.7 g/dl) with no significant difference between pre-frail and non-frail. This agrees with that obtained by Chaves et al. [17] who demonstrated a direct link in elderly women between the presence of anemia and the occurrence of frailty. The association between frailty and anemia may be due to decrease intake of foods, vitamins and iron or due to many causes of chronic blood loss which are common in elder persons. As regard white blood cells count, we found significant increase in WBCs count (14.22 + 3.7 cmm) in frail group compared to both pre-frail (10.9 + 2.7 cmm) and non-frail (8.7 + 1.6 cmm) with significant elevation in pre-frail compared to nonfrail. This agrees with that obtained by Ruggiero et al. Frailty is associated with increase in WBCs as well as CRP (which are recognized as an important markers of systemic inflammation), which suggests a role of inflammation in aging [19] . Interestingly, WBCs is the only biomarker in our study that showed significant difference between pre-frail and non-frail groups, suggesting that it may be useful for detection of pre-frailty, a suggestion that needs further studies to clarify. As regard serum albumin level, we found no significant difference between the three groups of the study (frail, pre-frail and non-frail) but this differ from other numerous studies that have reported higher mortality in community-dwelling older people with a low serum albumin level. Reuben et al. [20] reported that the relative risk for mortality in healthy non-disabled older persons was 2.2 times higher in subjects with an albumin level below 4 g/dl. Also Takata et al. [21] found that lower serum albumin concentrations were an independent predictor of mortality in 70 years old people in communitydwelling population. However, in agreement with our results, Schalk et al.
[22] found no association between lower serum albumin and functional decline in the elderly. This difference may be due to different nutritional status in these studies or due to the presence of diseases that affect serum albumin level.
As regard serum ALT, we found significant decrease in ALT levels (20.6+ 16.5 u/l) in frail group compared to both pre-frail (37.5+17.7 u/l) and non-frail (39.0+11.2 u.l) with no significant difference between pre-frail and non-frail. This agrees with the study of David et al.
[23] that revealed a substantially lower ALT level in older persons. The presence of significant decrease in serum ALT level in frail elderly compared to both pre-frail and non-frail in the absence of significant changes in other liver function tests may point to the value of low serum ALT as a biomarker of frailty, a result that needs further studies to verify. As regard serum CRP level, we found significant increase in CRP levels (27.4+8.1 mg/l) in frail group compared to both pre-frail (14.3+4.5 mg/l) and non-frail (7.5+5.5 mg/l) with no significant difference between pre-frail and non-frail. As regard TGUGT, we found significant prolongation in TGUGT in frail group compared to both pre-frail and non-frail with no significant difference between pre-frail and non-frail. This agrees with that obtained by Mathias et al. [12] who study of some biomarkers in frail elderly found prolonged TGUGT in geriatric patients and suggested that it can serve as performance test. The presence of non significant difference in some studied biomarkers (except WBCs) between pre-frail and non-frail groups of elderly may suggest that these changes appear late in the frail group only, and this motivate the search for other biomarkers that can differentiate between pre-frail and non-frail elderly in further studies. Our results suggest that the observed changes in some biomarkers with frailty; increasing age, WBCs, CRP and TGUGT and decreasing in ALT, Hb%, cholesterol, MAC, CC and BMI can suggest their use to detect frailty and to assess its degree of severity.
CONCLUSIONs AND RECOMMENDATIONS
1-There is high prevalence of frailty among studied elderly population, the causes of which need further studies to untravel. 2-The changes in biomarkers noticed in our frail elderly may suggest its use in the diagnosis and follow up of frailty, a suggestion that still in its infancy and needs further studies to verify. 3-The significant elevation of CRP and WBCs in frail elderly, which are markers of inflammation, may give support to the theory of inflammaging. 4-Being the only biomarker that differed significantly in pre-frail compared to non-frail group, further studies are suggested to assess ability of WBCs count in the detection of preclinical states of frailty as a single easy test to detect frailty while CRP increase in a later stage. 5-The impact of frailty on the quality of life is an important area of research, the results of which may help successful aging. 6-Further studies are also needed to assess whether frailty is a reversible event.
